FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899102912> ?p ?o ?g. }

• W2899102912 endingPage "5381" @default.
• W2899102912 startingPage "5373" @default.
• W2899102912 abstract "Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma Fatemeh Yazarlou,1 Seyed Javad Mowla,2 Vahid Kholghi Oskooei,3 Elahe Motevaseli,4 Leila Farhady Tooli,5 Mandana Afsharpad,6 Leila Nekoohesh,7 Nafiseh Sadat Sanikhani,4 Soudeh Ghafouri-Fard,3 Mohammad Hossein Modarressi1 1Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 2Faculty of Biological Sciences, Department of Genetics, Tarbiat Modares University, Tehran, Iran; 3Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 4Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; 5Department of Microbiology, School of Biology, College of Science, Tehran University, Tehran, Iran; 6Cancer Control Research Center, Cancer Control Foundation, Iran University of Medical Sciences, Tehran, Iran; 7Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran Background: Exosomes have been regarded as emerging tools for cancer diagnosis. Tumor-derived exosomes contain molecules that enhance cancer progression and affect immune responses. Material and methods: In the present study, we evaluated expression of seven cancer-testis antigens (CTAs) that are regarded as putative biomarkers and immunotherapeutic targets along with NMP22 in urinary exosomes of bladder cancer patients, healthy subjects and patients affected with nonmalignant urinary disorders. Results: Exosomal expression of MAGE-B4 was significantly higher in bladder cancer patients compared with normal samples (expression ratio=2.68, P=0.01). However, its expression was lower in bladder cancer patients compared with benign prostate hyperplasia (BPH) patients (expression ratio=0.17, P=0.01). Exosomal expression of NMP22 was significantly higher in bladder cancer patients compared with BPH patients (expression ratio=9.22, P=0.02). Expressions of other genes were not significantly different between bladder cancer patients and normal/nonmalignant samples. We found significant correlation between MAGE-A3 and MAGE-B4 expressions in exosomes obtained from controls. In addition, TSGA10 expression was correlated with expression of NMP22 in both cancer patients and controls. Conclusion: The present study provides evidences for differential expression of CTAs in urinary exosomes of bladder cancer patients and urogenital disorders and warrants further studies for assessment of their significance in cancer diagnosis and immunotherapeutic approaches. Keywords: cancer-testis antigen, bladder cancer, exosome" @default.
• W2899102912 created "2018-11-09" @default.
• W2899102912 creator A5013295187 @default.
• W2899102912 creator A5020653610 @default.
• W2899102912 creator A5021650062 @default.
• W2899102912 creator A5031221923 @default.
• W2899102912 creator A5038329042 @default.
• W2899102912 creator A5040312012 @default.
• W2899102912 creator A5046511626 @default.
• W2899102912 creator A5055601598 @default.
• W2899102912 creator A5083975126 @default.
• W2899102912 creator A5089563433 @default.
• W2899102912 date "2018-11-01" @default.
• W2899102912 modified "2023-09-25" @default.
• W2899102912 title "Urine exosome gene expression of cancer-testis antigens for prediction of bladder carcinoma" @default.
• W2899102912 cites W1704450602 @default.
• W2899102912 cites W1962635928 @default.
• W2899102912 cites W1966626972 @default.
• W2899102912 cites W1979216378 @default.
• W2899102912 cites W2013929037 @default.
• W2899102912 cites W2024883517 @default.
• W2899102912 cites W2027817214 @default.
• W2899102912 cites W2032469380 @default.
• W2899102912 cites W2036877110 @default.
• W2899102912 cites W2037739709 @default.
• W2899102912 cites W2055313665 @default.
• W2899102912 cites W206273122 @default.
• W2899102912 cites W2141003137 @default.
• W2899102912 cites W2160164594 @default.
• W2899102912 cites W2160916712 @default.
• W2899102912 cites W2175261477 @default.
• W2899102912 cites W2517304731 @default.
• W2899102912 cites W2744145142 @default.
• W2899102912 cites W2767035962 @default.
• W2899102912 cites W2767817687 @default.
• W2899102912 cites W2789582756 @default.
• W2899102912 cites W2793142085 @default.
• W2899102912 cites W92658572 @default.
• W2899102912 doi "https://doi.org/10.2147/cmar.s180389" @default.
• W2899102912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6225912" @default.
• W2899102912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30464633" @default.
• W2899102912 hasPublicationYear "2018" @default.
• W2899102912 type Work @default.
• W2899102912 sameAs 2899102912 @default.
• W2899102912 citedByCount "22" @default.
• W2899102912 countsByYear W28991029122019 @default.
• W2899102912 countsByYear W28991029122020 @default.
• W2899102912 countsByYear W28991029122021 @default.
• W2899102912 countsByYear W28991029122022 @default.
• W2899102912 countsByYear W28991029122023 @default.
• W2899102912 crossrefType "journal-article" @default.
• W2899102912 hasAuthorship W2899102912A5013295187 @default.
• W2899102912 hasAuthorship W2899102912A5020653610 @default.
• W2899102912 hasAuthorship W2899102912A5021650062 @default.
• W2899102912 hasAuthorship W2899102912A5031221923 @default.
• W2899102912 hasAuthorship W2899102912A5038329042 @default.
• W2899102912 hasAuthorship W2899102912A5040312012 @default.
• W2899102912 hasAuthorship W2899102912A5046511626 @default.
• W2899102912 hasAuthorship W2899102912A5055601598 @default.
• W2899102912 hasAuthorship W2899102912A5083975126 @default.
• W2899102912 hasAuthorship W2899102912A5089563433 @default.
• W2899102912 hasBestOaLocation W28991029121 @default.
• W2899102912 hasConcept C104317684 @default.
• W2899102912 hasConcept C121608353 @default.
• W2899102912 hasConcept C126322002 @default.
• W2899102912 hasConcept C142724271 @default.
• W2899102912 hasConcept C143998085 @default.
• W2899102912 hasConcept C145059251 @default.
• W2899102912 hasConcept C147483822 @default.
• W2899102912 hasConcept C203014093 @default.
• W2899102912 hasConcept C20518536 @default.
• W2899102912 hasConcept C2780352672 @default.
• W2899102912 hasConcept C2781261824 @default.
• W2899102912 hasConcept C29456083 @default.
• W2899102912 hasConcept C502701156 @default.
• W2899102912 hasConcept C502942594 @default.
• W2899102912 hasConcept C54355233 @default.
• W2899102912 hasConcept C71924100 @default.
• W2899102912 hasConcept C86803240 @default.
• W2899102912 hasConceptScore W2899102912C104317684 @default.
• W2899102912 hasConceptScore W2899102912C121608353 @default.
• W2899102912 hasConceptScore W2899102912C126322002 @default.
• W2899102912 hasConceptScore W2899102912C142724271 @default.
• W2899102912 hasConceptScore W2899102912C143998085 @default.
• W2899102912 hasConceptScore W2899102912C145059251 @default.
• W2899102912 hasConceptScore W2899102912C147483822 @default.
• W2899102912 hasConceptScore W2899102912C203014093 @default.
• W2899102912 hasConceptScore W2899102912C20518536 @default.
• W2899102912 hasConceptScore W2899102912C2780352672 @default.
• W2899102912 hasConceptScore W2899102912C2781261824 @default.
• W2899102912 hasConceptScore W2899102912C29456083 @default.
• W2899102912 hasConceptScore W2899102912C502701156 @default.
• W2899102912 hasConceptScore W2899102912C502942594 @default.
• W2899102912 hasConceptScore W2899102912C54355233 @default.
• W2899102912 hasConceptScore W2899102912C71924100 @default.
• W2899102912 hasConceptScore W2899102912C86803240 @default.
• W2899102912 hasLocation W28991029121 @default.
• W2899102912 hasLocation W28991029122 @default.

• next